Compositions and methods for targeted cytokine delivery
US-2024376169-A1 · Nov 14, 2024 · US
Compositions and methods to promote wound healing
US10478394B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10478394-B2 |
| Application number | US-201615557407-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 10, 2016 |
| Priority date | Mar 11, 2015 |
| Publication date | Nov 19, 2019 |
| Grant date | Nov 19, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present disclosure describes compositions and methods to promote wound healing. The compositions and methods include an interleukin-1 beta (IL-1B) receptor antagonist (IL-1Ra), such as anakinra.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of promoting healing of a chronic wound in a diabetic subject comprising administering to the chronic wound a therapeutically effective amount of a gel comprising a therapeutic agent consisting of a therapeutic protein consisting of the sequence provided in SEQ ID NO: 26 (anakinra), thereby promoting healing of the chronic wound. 2. The method of claim 1 , wherein the chronic wound is a diabetic ulcer. 3. The method of claim 1 , wherein the administering is topically administering. 4. The method of claim 1 , further comprising applying a wound dressing to the wound. 5. The method of claim 4 , wherein the administering and applying are achieved in one step. 6. The method of claim 4 , wherein the wound dressing is an adhesive bandage. 7. The method of claim 1 further comprising administering a platelet-derived growth factor and/or Becaplermin.
Assignees
Inventors
Classifications
- C07K14/545Primary
IL-1 · CPC title
of receptors · CPC title
Immunomodulating agents, i.e. cytokines, interleukins, interferons · CPC title
Medicaments; Biocides · CPC title
Hydrogels or hydrocolloids · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10478394B2 cover?
- The present disclosure describes compositions and methods to promote wound healing. The compositions and methods include an interleukin-1 beta (IL-1B) receptor antagonist (IL-1Ra), such as anakinra.
- Who is the assignee on this patent?
- Univ Wayne State
- What technology area does this patent fall under?
- Primary CPC classification C07K14/545. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).